Bangor Savings Bank’s AstraZeneca AZN Stock Holding History

Bangor Savings Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-152	Closed	-$27.9K	–	553
2025 Q4	$27.9K	Buy	152 +77	+103%	+$13.5K	﹤0.01%	344
2025 Q3	$11.5K	Buy	+75	New	+$11.4K	﹤0.01%	433
2024 Q4	–	Sell	-85	Closed	-$13.2K	–	551
2024 Q3	$13.2K	Hold	85	–	–	﹤0.01%	400
2024 Q2	$13.3K	Buy	+85	New	+$12.8K	﹤0.01%	391

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Bangor Savings Bank's AZN Position: Q1 2026 in Review

Bangor Savings Bank sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 152 shares — an estimated $27.9K sold.

Bangor Savings Bank first reported a position in AZN in Q2 2024 and held it in 4 quarters. The position peaked at $27.9K in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Bangor Savings Bank reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Bangor Savings Bank sold 152 AstraZeneca shares in Q1 2026, an estimated $27.9K.
Bangor Savings Bank first reported a position in AstraZeneca in Q2 2024 and held it in 4 quarters.
Bangor Savings Bank's AstraZeneca position peaked at $27.9K in Q4 2025.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Bangor Savings Bank's 13F filing for Q1 2026, filed 1 Apr 2026.